SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-035748
Filing Date
2020-08-04
Accepted
2020-08-04 07:04:28
Documents
85
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q epzm-10q_20200630.htm   iXBRL 10-Q 3133158
2 EX-3.1 epzm-ex31_326.htm EX-3.1 64861
3 EX-31.1 epzm-ex311_10.htm EX-31.1 8520
4 EX-31.2 epzm-ex312_7.htm EX-31.2 8503
5 EX-32.1 epzm-ex321_6.htm EX-32.1 6303
  Complete submission text file 0001564590-20-035748.txt   10658850

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA epzm-20200630.xsd EX-101.SCH 74882
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE epzm-20200630_cal.xml EX-101.CAL 61831
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE epzm-20200630_def.xml EX-101.DEF 258264
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE epzm-20200630_lab.xml EX-101.LAB 549971
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE epzm-20200630_pre.xml EX-101.PRE 437601
11 EXTRACTED XBRL INSTANCE DOCUMENT epzm-10q_20200630_htm.xml XML 1882908
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35945 | Film No.: 201070922
SIC: 2834 Pharmaceutical Preparations